Task Force Overview
From LipidomicsWiki
(Difference between revisions)
Line 12: | Line 12: | ||
| [[User:Michael_Wakelam | Prof. Micheal Wakelam]] | | [[User:Michael_Wakelam | Prof. Micheal Wakelam]] | ||
| [[User:Gerhard_Liebisch | PhD. Gerhard Liebisch]] | | [[User:Gerhard_Liebisch | PhD. Gerhard Liebisch]] | ||
- | | [[P01_UHREG | P01]], [[P02_UU | P02]], [[P04_INSERM | | + | | [[P01_UHREG | P01]], [[P02_UU | P02]], [[P04_INSERM |P04]], [[P06_ETHZ |P06]], [[P07_UNIGRAZ |P07]], [[P10_MPG |P10]], [[P11_BRC_HAS |P11]], [[P13_BABRAHAM |P13]], [[P14_UH |P14]], [[P15_UBO |P15]], [[P17_UMG_GOE |P17]], [[P18_BIOBASE |P18]], [[P19_ZORA |P19]], [[P21_INTEGROMICS |P21]], [[P22_UOXF.H7 |P22]], [[P25_ISB |P25]] |
|- | |- | ||
Line 19: | Line 19: | ||
| | | | ||
| | | | ||
- | | P01, P04, P09, P10, P11, P13, P14, P23, P24 | + | | [[P01_UHREG | P01]], [[P04_INSERM |P04]], [[P09_JUMC | P09]], [[P10_MPG |P10]], [[P11_BRC_HAS |P11]], [[P13_BABRAHAM |P13]], [[P14_UH |P14]], [[P23_MRC|P23]], [[P24_JKU | P24]] |
|- | |- |
Revision as of 09:16, 16 July 2008
Overiew Task Forces of LipidomicsNet
The following table shows an overview about the taskforces and its corresponding partners of LipidomicsNet.
Vertical Task Forces | Taskforce | Chair | CoChair | Partner(s) |
---|---|---|---|---|
Task Force I | Mass-spectrometric and chromatographic methods andpreanalytics for molecular lipid species analyses and stable isotope labelling | Prof. Micheal Wakelam | PhD. Gerhard Liebisch | P01, P02, P04, P06, P07, P10, P11, P13, P14, P15, P17, P18, P19, P21, P22, P25 |
Task Force II | Fluorescence-based lipidomic methods on intact cells, labelling lipidomic antibodies and proteins | P01, P04, P09, P10, P11, P13, P14, P23, P24 | ||
Task Force III | Affinity binder, ELISA and proteomic mass-spectrometric techniques and reagents | P01, P04, P06, P07, P16, P20 | ||
Task Force IV | Gene-, Taqman- and Bead-array reagents and preanalytics (RNA/DNA, Agilent, Affymetrix, Illumina, ABI TLDAs etc) | P01, P03, P06, P09 | ||
Task Force V | Mouse models | All WP 3 Partners | ||
Task Force VI | Clinical trials and human ethics | All WP 4-6 Partners | ||
Horizontal Task Forces | ||||
Task Force VII | Human/Mouse translational research | P01, P04, P06, P12, P13, P15 | ||
Task Force VIII | LipidomicNet-Bioinformatics | P01, P06, P10, P16, P17, P18, P21, P22, P25
| ||
Task Force IX | Dissemination, training and communication | All partners |
Together the specialized vertical and the integrative horizontal Task Forces (TFs) will
generate maximal integration and efficient dissemination and training.